1. Pleural Fluid Biomarkers
   José M. Porcel, 2013, Clinics in Chest Medicine CrossRef
2. Diagnostic value of mesothelin in pleural fluids: comparison with CYFRA 21-1 and CEA
   Rosa Filiberti et al, 2013, Medical Oncology CrossRef
3. Diagnostic value of soluble mesothelin-related peptides in pleural effusion for malignant pleural mesothelioma
   Ruiyue Gao et al, 2019, Medicine CrossRef
4. Significance of secretory leukocyte peptidase inhibitor in pleural fluid for the diagnosis of benign asbestos pleural effusion
   Takumi Kishimoto et al, 2021, Scientific Reports CrossRef
5. Biomarkers for malignant pleural mesothelioma: a meta-analysis
   Christina N Gillezeau et al, 2019, Carcinogenesis CrossRef
6. Clinical utility of diagnostic biomarkers in malignant pleural mesothelioma: a systematic review and meta-analysis
   Eline Schillebeeckx et al, 2021, European Respiratory Review CrossRef
7. Aberrant DNA methylation profile in pleural fluid for differential diagnosis of malignant pleural mesothelioma
   Masanori Fujii et al, 2012, Cancer Science CrossRef
8. Pleural effusion biomarkers and computed tomography findings in diagnosing malignant pleural mesothelioma: A retrospective study in a single center
   Takehiro Otoshi et al, 2017, PLOS ONE CrossRef
9. Hyaluronic acid in the pleural fluid of patients with malignant pleural mesothelioma
   Nobukazu Fujimoto et al, 2013, Respiratory Investigation CrossRef
10. Systematic Review, Meta-Analysis and Bioinformatic Analysis of Biomarkers for Prognosis of Malignant Pleural Mesothelioma
    Zhenhua Lu et al, 2022, Diagnostics CrossRef
11. Diagnostic values of soluble mesothelin-related peptides for malignant pleural mesothelioma: updated meta-analysis
    Ai Cui et al, 2014, BMJ Open CrossRef
12. Clinical Significance of Soluble CD26 in Malignant Pleural Mesothelioma
    Nobukazu Fujimoto et al, 2014, PLoS ONE CrossRef
13. Clinical Investigation of Benign Asbestos Pleural Effusion
    Nobukazu Fujimoto et al, 2015, Pulmonary Medicine CrossRef